picotamide has been researched along with Arterial Occlusive Diseases in 7 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Picotamide is an antiplatelet drug which inhibits thromboxane A2 (TxA2) synthase and antagonizes TxA2 receptors." | 2.68 | Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study. ( Longoni, A; Maderna, M; Milani, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neirotti, M | 1 |
| Molaschi, M | 1 |
| Ponzetto, M | 1 |
| Macchione, C | 1 |
| Poli, L | 1 |
| Bonino, F | 1 |
| Fabris, F | 1 |
| Milani, M | 1 |
| Longoni, A | 1 |
| Maderna, M | 1 |
| Craveri, A | 1 |
| Colombo, L | 1 |
| Cristina, M | 1 |
| Coloru, M | 1 |
| De Angeli, B | 1 |
| Lanfredini, M | 1 |
| Tazza, G | 1 |
| Tazza, R | 1 |
| Valentini, M | 1 |
| Leoni, G | 1 |
| Avenia, N | 1 |
| Ragusa, M | 1 |
| Canonico, V | 1 |
| Ammaturo, V | 1 |
| Guarini, P | 1 |
| Tedeschi, C | 1 |
| Nunziata, G | 1 |
| Nappi, A | 1 |
| Forgione, L | 1 |
| Rengo, F | 1 |
| Speziale, F | 1 |
| Taurino, M | 1 |
| Colella, E | 1 |
| Rizzo, L | 1 |
| Fiorani, P | 1 |
| Danese, C | 1 |
| Sergio, G | 1 |
| Giunta, G | 1 |
| Landi, MT | 1 |
| Renzulli, C | 1 |
| Panciocco, MG | 1 |
| De Rossi, MG | 1 |
| Perego, MA | 1 |
4 trials available for picotamide and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
Topics: Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Coagulation; Blood Viscosity; Double-Blind | 1994 |
Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
Topics: Arterial Occlusive Diseases; Diabetes Complications; Double-Blind Method; Hemodynamics; Humans; Inte | 1996 |
[Picotamide: use in chronic obliterative arteriopathies of the lower limbs].
Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Leg; Male; Middle Aged; Phthalic Acids; Time Fact | 1991 |
[The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Chronic Disease; Double-Blind Method; Female; Hum | 1991 |
3 other studies available for picotamide and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Female; Humans; Intermittent Claudication; Leg; | 1991 |
[Clinical study of picotamide in patients with vascular diseases].
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cerebrovascular Disorders; Drug Evaluat | 1989 |
Effects of prolonged picotamide therapy on platelet activity in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; beta-Thromboglobulin; Female; Humans; Male; Mi | 1988 |